Cargando…
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
Clinical oncology heavily relies on the use of radiotherapy, which often leads to merely transient responses that are followed by local or distant relapse. The molecular mechanisms explaining radioresistance are largely elusive. Here, we identified a dual role of autophagy in the response of cancer...
Autores principales: | Ko, A, Kanehisa, A, Martins, I, Senovilla, L, Chargari, C, Dugue, D, Mariño, G, Kepp, O, Michaud, M, Perfettini, J-L, Kroemer, G, Deutsch, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857616/ https://www.ncbi.nlm.nih.gov/pubmed/24037090 http://dx.doi.org/10.1038/cdd.2013.124 |
Ejemplares similares
-
Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014) -
Radiosensitization by a novel Bcl-2 and Bcl-X(L) inhibitor S44563 in small-cell lung cancer
por: Loriot, Y, et al.
Publicado: (2014) -
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
por: Sukkurwala, Abdul Qader, et al.
Publicado: (2014) -
The oncolytic peptide LTX-315 triggers immunogenic cell death
por: Zhou, H, et al.
Publicado: (2016) -
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
por: Wang, Yan, et al.
Publicado: (2020)